Life Science Cares Launches in Switzerland
Yahoo FinanceApr 19 11:12 ET
Express News | Molecular Partners AG : JP Morgan Cuts Target Price to $4.10 From $4.50
Moomoo 24/7Apr 18 00:05 ET
Press Release: Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX
Dow JonesApr 17 11:12 ET
Press Release: Molecular Partners Publishes Invitation to Annual General Meeting 2024
Molecular Partners Publishes Invitation to Annual General Meeting 2024 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: M
Dow JonesMar 26 09:26 ET
Molecular Partners AG: Strong Financials & Promising Pipeline Justify Buy Rating
TipRanksMar 15 15:15 ET
Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
Yahoo FinanceMar 1 16:00 ET
Retail Investors Account for 43% of Molecular Partners AG's (VTX:MOLN) Ownership, While Hedge Funds Account for 33%
Yahoo FinanceDec 22, 2023 02:22 ET
Tang Capital Management LLC Buys Shares of 15,681 Molecular Partners AG (NASDAQ:MOLN)
Tang Capital Management LLC bought a new stake in shares of Molecular Partners AG (NASDAQ:MOLN – Get Rating) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 15,681
Financial News LiveMar 8, 2023 13:03 ET
Molecular Partners Starts Early-stage Study of Blood Cancer Drug MP0533
Seeking AlphaJan 16, 2023 06:01 ET
Hedge Funds Own 28% of Molecular Partners AG (VTX:MOLN) Shares but Individual Investors Control 41% of the Company
Yahoo FinanceJan 12, 2023 06:31 ET
Molecular Partners AG (NASDAQ:MOLN) Short Interest Update
Molecular Partners AG (NASDAQ:MOLN – Get Rating) was the target of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 11,700 shares, a d
Defense WorldJan 3, 2023 03:31 ET
Molecular Partners AG (OTCMKTS:MLLCF) Sees Significant Decline in Short Interest
Molecular Partners AG (OTCMKTS:MLLCF – Get Rating) was the target of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 113
Defense WorldJan 2, 2023 02:41 ET
Molecular Partners AG (OTCMKTS:MLLCF) Short Interest Update
Molecular Partners AG (OTCMKTS:MLLCF – Get Rating) was the recipient of a significant decline in short interest in November. As of November 30th, there was short interest totalling 162,100 shares, a
Defense WorldDec 18, 2022 01:21 ET
Molecular Partners AG's (VTX:MOLN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Yahoo FinanceDec 2, 2022 00:16 ET
FY2023 EPS Estimates for Molecular Partners AG (NASDAQ:MOLN) Cut by Analyst
Molecular Partners AG (NASDAQ:MOLN – Get Rating) – Equities researchers at SVB Leerink decreased their FY2023 earnings per share estimates for shares of Molecular Partners in a research note issued
Defense WorldNov 28, 2022 02:01 ET
FY2022 EPS Estimates for Molecular Partners AG (NASDAQ:MOLN) Raised by SVB Leerink
Molecular Partners AG (NASDAQ:MOLN – Get Rating) – Equities researchers at SVB Leerink raised their FY2022 EPS estimates for shares of Molecular Partners in a note issued to investors on Wednesday
Defense WorldNov 25, 2022 01:21 ET
Molecular Partners AG (OTCMKTS:MLLCF) Short Interest Up 36.4% in September
Molecular Partners AG (OTCMKTS:MLLCF – Get Rating) saw a large increase in short interest in September. As of September 30th, there was short interest totalling 171,900 shares, an increase of 36.4%
Financial News LiveOct 17, 2022 21:21 ET
Molecular Partners AG (OTCMKTS:MLLCF) Short Interest Down 6.4% in September
Molecular Partners AG (OTCMKTS:MLLCF – Get Rating) saw a large decrease in short interest during the month of September. As of September 15th, there was short interest totalling 126,000 shares, a de
Defense WorldOct 3, 2022 03:41 ET
Molecular Partners AG (NASDAQ:MOLN) Short Interest Down 26.4% in September
Molecular Partners AG (NASDAQ:MOLN – Get Rating) was the target of a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 19,800 shares
kopsourceOct 2, 2022 00:22 ET
Molecular Partners AG (NASDAQ:MOLN) Short Interest Down 9.4% in August
Molecular Partners AG (NASDAQ:MOLN – Get Rating) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totalling 26,900 shares, a decline of 9
Financial News LiveSep 21, 2022 07:32 ET
No Data
No Data